DrugsControl Media Services
DrugsControl.org

News Detail

FDA warns Granules India over cleanliness and poor record keeping (05-03-2025)

Maryland, 5 March 2025: The US Food and Drug Administration (FDA) recently issued two warning letters to companies in India and the US for various violations of good manufacturing practices (GMPs) related to the production of drug products. In both cases, investigators identified......
View Details

Source : Regulatory Focus
US Food and Drug Administration (FDA) Granules India Limited Gagillapur Village good manufacturing practices (GMPs)

Related News